Risk of declining sales due to critical defects in software products
First written in FY2018. 1 of 4 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2021: 1 of 10 companies on the "Worse" side.
1 other company's latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「For AI-related products and services, we are introducing appropriate testing methods and establishing quality control processes. For cloud services, we are adopting redundant configurations and developing procedures for responding to failures, working as a group to provide highly reliable products and services.」
To address the risk of defects in AI and cloud services, the company specified measures including developing testing methods, quality control processes, redundant configurations and failure-response procedures. - FY2025Added uncertainty specific to AIAnnual report
「In particular, systems and solutions using generative AI technology provided by our subsidiary 株式会社WEEL may involve uncertainties that differ from those of conventional software due to the characteristics of AI.」
In addition to the risk of defects in conventional software, the company explicitly identified uncertainties specific to systems and solutions using generative AI. - FY2020RestatedAnnual report
「Our group is working to minimize the occurrence of this risk by strengthening its product quality control structure, including obtaining ISO9001 certification and establishing a quality control department.」
The company has continued to disclose the risk of declining sales due to critical defects discovered after product implementation and specified measures including obtaining ISO9001 certification and establishing a quality control department. - FY2018First statedAnnual report
「Accordingly, customers may discover defects after implementing our group's products. Although our contracts with customers provide that the discovery of such defects will not result in a direct loss to our group, subsequent sales of the relevant product may decline, which could affect our operating results, financial condition and other aspects of our business.」
Although rigorous testing is conducted during the development process, the company identifies as a risk the possibility that defects may be discovered after implementation, resulting in lower subsequent sales of the relevant product.